ROBERT HERSHBERG Insider Trading $RXRX RECURSION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT HERSHBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT HERSHBERG. ROBERT HERSHBERG is Sr. VP & Chief Medical Officer in DENDREON CORP ($DNDN) and Director in NanoString Technologies Inc ($NSTG) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in RECURSION PHARMACEUTICALS, INC. ($RXRX).
ROBERT HERSHBERG in RECURSION PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT HERSHBERG: Director
Holdings: 0 shares
Latest Transaction: Apr 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT HERSHBERG in RECURSION PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADPT, DNDN, NSTG, RXRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 2.22 | 525,000 | 1,165,500 | 525,000 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 2.22 | 525,000 | 1,165,500 | 0 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 18.00 | 12,500 | 225,000 | 12,500 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | C | 18.00 | 12,500 | 225,000 | 0 | |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Buy | C | 0.00 | 6,250 | 0 | 6,250 | 0 to 6.3 K |
| Apr 22 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Sell | C | 0.00 | 6,250 | 0 | 0 | 6.3 K to 0 (-100.00 %) |
| Apr 19 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Option Exercise | A | 18.00 | 12,500 | 225,000 | 12,500 | |
| Apr 19 2021 | RXRX | RECURSION PHARMACE ... | HERSHBERG ROBERT | Director | Grant | A | 0.00 | 6,250 | 0 | 6,250 | 0 to 6.3 K |
Page: 1